PACTR201602001308660

interventional pulmonology

Bronchoscopic Lung Volume Reduction With Silver Nitrate Instillation In Patients With Emphysema, efficacy and safety
Mansoura university hospital·Not Applicable·Pan Africa Clinical Trials Registry·drugRecruiting
Study focus
Disease/Condition
Respiratory; Other
Intervention type
drug
Sponsor & location
Primary sponsor
Mansoura university hospital
Funder
Mansoura University Hospital
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
May 01, 2015
End date
Jan 01, 1900
Summary

Emphysema is a parenchymal tissue destruction resulting from chronic inflammatory response to inhaled cigarette smoke and other noxious agents that disrupt normal repair mechanisms and results in small airway fibrosis. These pathological changes lead to air trapping and progressive air flow limitation. Surgical lung volume reduction (LVRS) can be performed for patients with advanced emphysema. However, serious post-surgical complications, including cardiac ischaemia, arrhythmia and pulmonary embolus, were observed more frequently. Lung transplantation also improves pulmonary function, symptoms, functional capacity, and quality of life in patients with advanced emphysema, but Chronic rejection remains a major unresolved problem among patients who undergo lung transplantation, and is associated with a 50% 5 year mortality. Therefore, minimally invasive techniques had been proposed to reduce lung volume in those patients without undergoing open thoracotomy. Different endoscopic LVR (ELVR) systems are undergoing evaluation to avoid surgical LVRS without the concomitant surgical morbidity and mortality. For example, endobronchial valve and endobronchial coils but the cost of these methods is high. Silver nitrate is a cauterizing agent if applied to the mucosa it will lead to coagulation of cellular protein with eschar formation, degenerative changes in the musculature and the bronchial wall and surrounding parenchyma showed marked edema so, if silver nitrate is applied to bronchial mucosa, it will lead to bronchial mucosa swelling and ulceration with subsequent complete stenosis of airway.The aim of work is to assess the efficacy and safety of use of Silver Nitrate in bronchoscopic lung.

ICD-10 classifications
Other specified respiratory disordersOther respiratory disordersOther diseases of the respiratory systemOther postprocedural respiratory disordersOther respiratory conditions due to chemicals, gases, fumes and vapours
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201602001308660
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201602001308660 through Pure Global AI's free database. This Not Applicable trial is sponsored by Mansoura university hospital and is currently Recruiting. The study focuses on Respiratory; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.